CLINICAL TRIALS PROFILE FOR NEOSPORIN
✉ Email this page to a colleague
All Clinical Trials for NEOSPORIN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00386958 ↗ | A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers | Completed | Joseph Eye Hospital | Phase 2 | 2002-11-01 | Bacterial corneal ulcers are a leading cause of pediatric blindness in underdeveloped countries due to a lack of antibiotic availability and affordability, among other reasons. Povidone-iodine, an inexpensive and readily available broad-spectrum antimicrobial agent, may be an effective and affordable treatment for corneal ulcers, allowing preservation of sight for those afflicted with this disease. |
| NCT00386958 ↗ | A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers | Completed | Kolokotrones Family Foundation | Phase 2 | 2002-11-01 | Bacterial corneal ulcers are a leading cause of pediatric blindness in underdeveloped countries due to a lack of antibiotic availability and affordability, among other reasons. Povidone-iodine, an inexpensive and readily available broad-spectrum antimicrobial agent, may be an effective and affordable treatment for corneal ulcers, allowing preservation of sight for those afflicted with this disease. |
| NCT00386958 ↗ | A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers | Completed | L.V. Prasad Eye Institute | Phase 2 | 2002-11-01 | Bacterial corneal ulcers are a leading cause of pediatric blindness in underdeveloped countries due to a lack of antibiotic availability and affordability, among other reasons. Povidone-iodine, an inexpensive and readily available broad-spectrum antimicrobial agent, may be an effective and affordable treatment for corneal ulcers, allowing preservation of sight for those afflicted with this disease. |
| NCT00386958 ↗ | A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers | Completed | Research to Prevent Blindness | Phase 2 | 2002-11-01 | Bacterial corneal ulcers are a leading cause of pediatric blindness in underdeveloped countries due to a lack of antibiotic availability and affordability, among other reasons. Povidone-iodine, an inexpensive and readily available broad-spectrum antimicrobial agent, may be an effective and affordable treatment for corneal ulcers, allowing preservation of sight for those afflicted with this disease. |
| NCT00386958 ↗ | A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers | Completed | Thrasher Research Fund | Phase 2 | 2002-11-01 | Bacterial corneal ulcers are a leading cause of pediatric blindness in underdeveloped countries due to a lack of antibiotic availability and affordability, among other reasons. Povidone-iodine, an inexpensive and readily available broad-spectrum antimicrobial agent, may be an effective and affordable treatment for corneal ulcers, allowing preservation of sight for those afflicted with this disease. |
| NCT00386958 ↗ | A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers | Completed | University of California, Los Angeles | Phase 2 | 2002-11-01 | Bacterial corneal ulcers are a leading cause of pediatric blindness in underdeveloped countries due to a lack of antibiotic availability and affordability, among other reasons. Povidone-iodine, an inexpensive and readily available broad-spectrum antimicrobial agent, may be an effective and affordable treatment for corneal ulcers, allowing preservation of sight for those afflicted with this disease. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NEOSPORIN
Condition Name
Clinical Trial Locations for NEOSPORIN
Trials by Country
Clinical Trial Progress for NEOSPORIN
Clinical Trial Phase
Clinical Trial Sponsors for NEOSPORIN
Sponsor Name
